Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.

New York, N.Y. / 500NewsWire / March 14, 2024 / Strainsforpains, inc. (OTC PINK:EBYH) Strainsforpains, Inc. has entered into a

The post Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp. appeared first on CorporatePRwire.

Continue Reading